Related Experiment Video
Updated: Jun 11, 2026

Use of a Hanging-weight System for Liver Ischemia in Mice
Published on: August 7, 2012
Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion
1Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.
Objective:
The objective of this study was to investigate the protective effect and mechanisms of nuclear factor (NF)-kappaB decoy oligodeoxynucleotides (ODN) on rat liver grafts following ischemia-reperfusion injury (IRI).
Methods:
Animals were randomly divided into 3 groups (n = 8): control ischemia-reperfusion (IR) and decoy ODN groups; in the last cohort donor grafts were transfected with 120 microg NF-kappaB decoy ODN before procurement. Following 2 hours of reperfusion, NF-kappaB binding activity was detected in isolated Kupffer cells (KCs) using electrophoretic mobility shift assays (EMSA). Tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 messenger RNA (mRNA) expressions were analyzed using reverse transcriptase polymerase chain reaction (RT-PCR) methods. Liver tissue and blood serum were collected for histopathologic examination and liver function test, respectively.
Results:
The NF-kappaB binding activity, TNF-alpha and IL-6 mRNA expression as well as serum ALT and total bilirubin levels were significantly increased compared with the control group following reperfusion (P < .01). A large number of hepatocytes showed degeneration and necrosis. However, these indices were significantly ameliorated among the decoy ODN group (P < .01) with preserved hepatic lobule architecture.
Conclusion:
KCs NF-kappaB activation following reperfusion plays an important role in IRI after liver transplantation. The decoy strategy showed an apparent effect to suppress NF-kappaB activation and inhibit production of downstream cytokines, thereby protecting liver grafts from IRI.
Insights
Nuclear factor-kappaB (NF-κB) decoy oligodeoxynucleotides (ODN) protect rat liver grafts from ischemia-reperfusion injury (IRI). This strategy suppresses NF-κB activation and reduces inflammatory cytokine production, preserving liver function.
Area of Science:
- Hepatology
- Transplantation Immunology
- Molecular Biology
Background:
- Ischemia-reperfusion injury (IRI) is a significant complication in liver transplantation.
- Nuclear factor-kappaB (NF-κB) activation in Kupffer cells (KCs) contributes to IRI pathogenesis.
- Targeting NF-κB offers a potential therapeutic strategy for liver graft protection.
Purpose of the Study:
- To investigate the protective effects of NF-κB decoy oligodeoxynucleotides (ODN) on rat liver grafts subjected to IRI.
- To elucidate the underlying mechanisms of NF-κB decoy ODN in mitigating IRI.
Main Methods:
- Rats were allocated to control, IRI, and NF-κB decoy ODN treatment groups.
- Donor liver grafts were transfected with NF-κB decoy ODN prior to procurement.
- NF-κB binding activity, TNF-α and IL-6 mRNA expression, and liver function tests were assessed post-reperfusion.
Main Results:
- IRI significantly increased NF-κB activity, pro-inflammatory cytokine mRNA (TNF-α, IL-6), and markers of liver damage (ALT, bilirubin).
- Hepatocyte degeneration and necrosis were observed in IRI group.
- NF-κB decoy ODN treatment significantly ameliorated these IRI-induced changes, preserving liver architecture.
Conclusions:
- KC NF-κB activation is a key mediator of IRI in liver transplantation.
- NF-κB decoy ODN effectively suppresses NF-κB activation and downstream cytokine production.
- This decoy strategy demonstrates significant protective effects against liver graft IRI.

